Improved Efficacy of Delayed Treatment with Human Bone Marrow-Derived Stromal Cells Evaluated in Rats with Spinal Cord Injury
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031548 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marta Aguado-Garrido und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Nacional de Parapléjicos, 45071 Toledo, Spain. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, national research, ERDF A way of making Europe/EU.
Abstract (Originalsprache)
The treatment of spinal cord injury (SCI) with uncultivated human bone marrow-derived stromal cells (bmSCs) prepared by negative selection has been proposed to be therapeutically superior to treatment with stem cells that were expanded in vitro. To explore their use in clinical trials, we studied the functional effects of delayed application at 7 days after SCI by testing different doses of bmSCs. Spinal cord contusion injury was induced in adult male Wistar rats at the thoracic level T9. Human bmSCs were prepared by negative selection without expansion in vitro (NeuroCellsTM). Treatment consisted of one 150 µL injection into the cisterna magna containing 0.5 or 2.5 million fresh bmSCs or 2.5 million bmSCs. The recovery of motor functions was evaluated during a surveillance period of six weeks (6 W), during which spinal cords were assessed histologically. Treatment resulted in a significant, dose-dependent therapeutic effect on the recovery of motor performance. The histological analysis revealed a lower degree of axonal degeneration and better survival of neurons and oligodendrocytes in bmSCs treated rats. Our results support delayed intrathecal application of bmSCs prepared by negative selection without expansion in vitro as a treatment of SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Nacional de Parapléjicos, 45071 Toledo, Spain.
- Neuroplast BV, 6222 NK Maastricht, The Netherlands.
- EURON Graduate School of Neuroscience, Maastricht University, 6229 ER Maastricht, The Netherlands.
ORCID-Profile: Marta Aguado-Garrido, Lorenzo Romero-Ramírez, Vinnitsa Buzoianu-Anguiano, Enrique Pérez-Rizo, Jörg Mey
Förderung
- Ministerio de Ciencia e Innovación
- national research
- ERDF A way of making Europe/EU
- Neuroplast BV
Zitieren
APA
Aguado-Garrido, M., García-Rama, C., Romero-Ramírez, L., Buzoianu-Anguiano, V., Pérez-Rizo, E., Kramer, B. W., & Mey, J. (2024). Improved Efficacy of Delayed Treatment with Human Bone Marrow-Derived Stromal Cells Evaluated in Rats with Spinal Cord Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031548
Vancouver
Aguado-Garrido M, García-Rama C, Romero-Ramírez L, Buzoianu-Anguiano V, Pérez-Rizo E, Kramer BW, et al. Improved Efficacy of Delayed Treatment with Human Bone Marrow-Derived Stromal Cells Evaluated in Rats with Spinal Cord Injury. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031548
BibTeX
@article{AguadoGarrido2024,
author = {Aguado-Garrido, Marta and García-Rama, Concepción and Romero-Ramírez, Lorenzo and Buzoianu-Anguiano, Vinnitsa and Pérez-Rizo, Enrique and Kramer, Boris W and Mey, Jörg},
title = {Improved Efficacy of Delayed Treatment with Human Bone Marrow-Derived Stromal Cells Evaluated in Rats with Spinal Cord Injury},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031548}
}
EUVIMED